Funding for this research was provided by:
National Human Genome Research Institute (U01 HG007436-04)
U.S. Food and Drug Administration (U01 FD004979)
Received: 25 February 2018
Accepted: 18 September 2018
First Online: 27 September 2018
Ethics approval and consent to participate
: This research was reviewed and approved by the Mexican Institute of Social Security (IMSS)‘s National Scientific Research Committee and its National Bioethics Committee, under protocol number R-2017-785-010, and locally by IMSS’ Local Research and Ethics Committee, under specific protocol number R-2017-1602-14 HGR1 Charo, Michoacan. Stanford’s Institutional Review Board provided a non-human subject determination under eProtocol: 40704. Researchers only received access to non-identifiable data under the considerations of the applicable Mexican bylaws on health research, patient privacy, and electronic medical records. Consent was not required.
: Not applicable.
: RAR declares to be IMSS’s state delegate in Michoacan, overseeing the hospital mentioned in this study. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.